Physician profile
Karrin E Licht
NPI 1780620070
$523.33
in general payments reported to CMS, 2019-2025
10 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.38 · 2024: $286 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.02 | 2024-2025 | |
| Novo Nordisk INC | $85.29 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $33.14 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $22.38 | 2023 | Proquad, Vaxneuvance, Vaxelis |
| Corium, LLC | $21.21 | 2024 | Azstarys |
| Daiichi Sankyo INC. | $20.06 | 2025 | Injectafer |
| Pfizer INC. | $16.63 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $14.16 | 2024 | Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $14.01 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karrin Licht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.